Crescent

Women's Health Continuum

The governance layer women's health has never had.

Confidential · May 2026

"She sees five specialists. Nobody sees her."

7 specialists. 4 EMR systems. 3 years. One woman's journey through fertility, pregnancy, autoimmune, and GI care — with nobody holding the thread.

84% of maternal deaths are preventable. (CDC MMRC)

$7.00 PMPM

The cost of uncoordinated women's health complexity per female member per month

$8.4M in annual waste per 100,000-member book of business

The fragmentation creates downstream claims, redundant testing, preventable admissions, and missed interventions across every sex-linked condition.

What Crescent Does

Crescent sits between the payer and the women's health delivery system.

We review utilization, flag coordination failures, enforce clinical protocols, and manage transitions across every sex-linked condition — fertility through menopause.

One layer. Seven modules. No member app required.

Seven Modules. One Continuum.

Acute
Fertility Management
Maternity & OB/GYN Governance
Chronic
Autoimmune Specialty
GI / Digestive Health
Rx Management
Labs & Diagnostics
Continuous
Care Navigation & Steering

Point solutions address symptoms. Crescent governs the architecture.

Fertility Maternity Autoimmune GI Rx Labs Nav
Maven • • •
Progyny • •
Pomelo • •
Visana • •
Crescent • • • • • • •

Maven: $1.7B. Progyny: $1.29B revenue. Pomelo: $92M raised. None governs the full continuum.

The Economics

NICU avoidance$2,520,000
Autoimmune flare$3,200,000
C-section reduction$176,000
Biosimilar conversion$1,400,000
GI site-of-care$680,000
Lab optimization$424,000
Total$8,400,000

Largest lever: autoimmune flare management — 38% of total savings.

Fee $1.50 – $3.00 PMPM
ROI 2.3x – 4.7x
Performance Guarantee

Fees waived in Year 2 if savings don't exceed fees in Year 1.

Revenue Trajectory

$1.1M
Year 1
$8.2M
Year 2
$37.8M
Year 3
$78.5M
Year 4
$125.4M
Year 5

Cash-flow positive by Q3 of Year 2.

Capital accelerates the timeline. The model works without it.

Go-to-Market

Phase 1: Employer Direct + TPA Channel
First Revenue · Months 1–12
Pipeline active. TPA conversations underway.
Phase 2: Regional Health Plans
Scale Revenue · Months 6–18
Leveraging employer outcomes data as proof points.
Phase 3: Medicaid MCOs + National Plans
Structural Revenue · Months 12–36
Aligned to CMS maternal health mandates and HEDIS measures.

Conversations begin across all channels from Day 1.

Joe Nalley

Specialty risk executive managing six condition-specific books — including maternity and musculoskeletal — across millions of lives at a top-three national health plan.

Prior governance methodology applied across 65,234 specialty pharmacy patients established the approach Crescent extends to women's health.

Part of the Corridor family: Cadence (specialty governance), Curated (episode-based care), Caliber (claims verification), Covenant (delegation oversight).

We're looking for founding partners.

One self-funded employer (25,000–100,000 lives) willing to pilot the full model.
One TPA partner with an existing employer book expressing demand for women's health management.
One regional health plan willing to run a 12-month pilot.

Pilot cohort: Q3 2026. Three founding partners.

45 days to implement. No integration required.

Floor-rate pricing. Direct founder access. Full-fee-at-risk guarantee.

Joe Nalley

joe.nalley@showyourwork.health

30-minute walkthrough available. I'll bring the numbers for your book.